 REDWOOD CITY, Calif., July 12, 2021 GLOBE NEWSWIRE -- Coherus BioSciences, Inc. Coherus or the Company, Nasdaq: CHRS, today announced that effective July 6, 2021, the compensation committee of the Companys board of directors granted options to purchase an aggregate of 221,500 shares of the common stock of the Company to newly hired employees with a per share exercise price of 13.63, the closing trading price on the grant date. A newly hired Vice President was granted options for 45,000 shares; fourteen additional non-officer employees were granted options to purchase an aggregate of 176,500 shares. 